These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37533598)
1. Electroconvulsive therapy for treating patients with agitation and related behavioral disorders due to dementia: a systematic review. Stella F; Radanovic M; Gallucci-Neto J; Forlenza OV Dement Neuropsychol; 2023; 17():e20230007. PubMed ID: 37533598 [TBL] [Abstract][Full Text] [Related]
2. Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) - a promising option. Glass OM; Forester BP; Hermida AP Int Psychogeriatr; 2017 May; 29(5):717-726. PubMed ID: 28095946 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072 [TBL] [Abstract][Full Text] [Related]
4. Electroconvulsive Therapy for Agitation and Aggression in Dementia: A Systematic Review. van den Berg JF; Kruithof HC; Kok RM; Verwijk E; Spaans HP Am J Geriatr Psychiatry; 2018 Apr; 26(4):419-434. PubMed ID: 29107460 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of ECT for Behavioral and Psychological Symptoms of Dementia (BPSD): A Retrospective Chart Review. Hermida AP; Tang YL; Glass O; Janjua AU; McDonald WM Am J Geriatr Psychiatry; 2020 Feb; 28(2):157-163. PubMed ID: 31668364 [TBL] [Abstract][Full Text] [Related]
6. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia. Acharya D; Harper DG; Achtyes ED; Seiner SJ; Mahdasian JA; Nykamp LJ; Adkison L; Van der Schuur White L; McClintock SM; Ujkaj M; Davidoff DA; Forester BP Int J Geriatr Psychiatry; 2015 Mar; 30(3):265-73. PubMed ID: 24838521 [TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive therapy in individuals with dementia/major NCD presenting with behavioral symptoms: a systematic review. Bachu AK; Kotapati VP; Kainth T; Patel R; Youssef NA; Tampi RR Int Psychogeriatr; 2023 May; ():1-16. PubMed ID: 37170574 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. The Treatment of Disruptive Vocalization in Dementia (Behavioral and Psychological Symptoms of Dementia) With Electroconvulsive Therapy: A Case Series. Lau TE; Babani PK; McMurray LA J ECT; 2017 Jun; 33(2):e9-e13. PubMed ID: 28009620 [TBL] [Abstract][Full Text] [Related]
11. Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials. McManus KR; Lapid MI; Forester BP; Mueller M; Hermida AP; Nykamp L; Harper DG; Seiner SJ; Sanghani S; Patrick R; Gentry MT; Kung S; Leal JC; Johnson EK; Petrides G J ECT; 2022 Sep; 38(3):165-170. PubMed ID: 35220356 [TBL] [Abstract][Full Text] [Related]
13. Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation-Liaison Service. Glass OM; Hermida AP; Hershenberg R; Schwartz AC Curr Psychiatry Rep; 2020 Apr; 22(5):21. PubMed ID: 32285305 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia. Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337 [TBL] [Abstract][Full Text] [Related]
15. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series. Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012 [TBL] [Abstract][Full Text] [Related]
16. Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia. Isserles M; Daskalakis ZJ; Kumar S; Rajji TK; Blumberger DM J Alzheimers Dis; 2017; 57(1):45-51. PubMed ID: 28222513 [TBL] [Abstract][Full Text] [Related]
17. Valproic acid for agitation in dementia. Lonergan ET; Cameron M; Luxenberg J Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227 [TBL] [Abstract][Full Text] [Related]
18. Algorithm-based pain management for people with dementia in nursing homes. Manietta C; Labonté V; Thiesemann R; Sirsch EG; Möhler R Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013339. PubMed ID: 35363380 [TBL] [Abstract][Full Text] [Related]
19. Treatment of agitation and aggression in four demented patients using ECT. Grant JE; Mohan SN J ECT; 2001 Sep; 17(3):205-9. PubMed ID: 11528314 [TBL] [Abstract][Full Text] [Related]
20. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. Salzman C; Jeste DV; Meyer RE; Cohen-Mansfield J; Cummings J; Grossberg GT; Jarvik L; Kraemer HC; Lebowitz BD; Maslow K; Pollock BG; Raskind M; Schultz SK; Wang P; Zito JM; Zubenko GS J Clin Psychiatry; 2008 Jun; 69(6):889-98. PubMed ID: 18494535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]